DeepMed Research

SPECTRUM PHARMACEUTICALS, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1987-01-01

Employees: 101

Market Cap: -

Website: http://www.sppirx.com

Clinical Trials

Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients

Phase 3

Terminated

Conditions: Peripheral T-cell Lymphoma

Interventions: Drug: Pralatrexate Injection

First Posted Date: 2011-08-22

Last Posted Date: 2021-11-19

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 21

Registration Number: NCT01420679

Locations: 🇦🇺
Monash Medical Centre, Clayton, Victoria, Australia
🇧🇪
AZ Sint-Jan, Brugge, Belgium
🇬🇧
Royal Cornwall Hospital, Truro, Cornwall, United Kingdom

and more 52 locations

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

Phase 3

Terminated

Conditions: Bladder Cancer

Interventions: Drug: Placebo
Drug: Apaziquone

First Posted Date: 2011-08-05

Last Posted Date: 2016-12-13

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 66

Registration Number: NCT01410565

Locations: 🇨🇦
G. Steinhoff Clinical Research Pacific Urologic Research, Victoria, British Columbia, Canada
🇨🇦
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
🇺🇸
Idaho Urologic Institute, P.A., Meridian, Idaho, United States

and more 44 locations

A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

Phase 1

Completed

Conditions: Hematological Malignancy
Solid Tumor

Interventions: Drug: Belinostat, Warfarin

First Posted Date: 2011-03-17

Last Posted Date: 2015-09-23

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 27

Registration Number: NCT01317927

Locations: 🇺🇸
Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, United States

International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Ozarelix
Drug: Goserelin

First Posted Date: 2010-12-03

Last Posted Date: 2021-10-05

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 203

Registration Number: NCT01252693

Locations: 🇺🇸
Urology Clinics of North Texas, Dallas, Texas, United States
🇺🇸
The Urology Center of Colorado, Denver, Colorado, United States
🇺🇸
Urology San Antonio Research, San Antonio, Texas, United States

Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma, B-Cell

Interventions: Drug: Pralatrexate
Dietary Supplement: Vitamin B12
Dietary Supplement: Folic Acid

First Posted Date: 2009-10-21

Last Posted Date: 2021-11-05

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 29

Registration Number: NCT00998946

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
Tower Cancer Research Foundation, Beverly Hills, California, United States
🇺🇸
Owsley Brown Frazier Cancer Center, Louisville, Kentucky, United States

and more 8 locations

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

Phase 2

Completed

Conditions: Peripheral T-cell Lymphoma

Interventions: Drug: Belinostat

First Posted Date: 2009-03-20

Last Posted Date: 2021-10-29

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 129

Registration Number: NCT00865969

Locations: 🇺🇸
New York University, New York, New York, United States
🇺🇸
Upstate Medical Univeristy Syracuse, Syracuse, New York, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

and more 114 locations

Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors

Phase 1

Completed

Conditions: Small Cell Lung Cancer
Solid Tumors
Ovarian Cancer

Interventions: Drug: Topotecan Liposomes Injection (TLI)

First Posted Date: 2008-10-03

Last Posted Date: 2020-11-13

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 14

Registration Number: NCT00765973

Locations: 🇺🇸
South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States
🇺🇸
Barbara Ann Karmanos Cancer Center, Detroit, Michigan, United States

Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)

Phase 2

Terminated

Conditions: Benign Prostatic Hyperplasia (BPH)
Lower Urinary Tract Symptoms (LUTS)

Interventions: Drug: Placebo
Drug: ozarelix

First Posted Date: 2008-08-28

Last Posted Date: 2021-11-22

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 28

Registration Number: NCT00743184

Locations: 🇺🇸
California Professional Research, Newport Beach, California, United States

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash

Phase 1

Completed

Conditions: EGFR Inhibitor-associated Rash

Interventions: Drug: Menadione Topical Lotion

First Posted Date: 2008-04-11

Last Posted Date: 2020-11-13

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 18

Registration Number: NCT00656786

Locations: 🇺🇸
Solano Clinical Research, Vallejo, California, United States
🇺🇸
Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois, United States
🇨🇦
McGill University, Montreal, Quebec, Canada

and more 4 locations

A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma

Phase 1

Completed

Conditions: Carcinoma

Interventions: Drug: SPI-1620

First Posted Date: 2008-02-13

Last Posted Date: 2013-10-21

Lead Sponsor: Spectrum Pharmaceuticals, Inc

Target Recruit Count: 36

Registration Number: NCT00613691

Locations: 🇺🇸
START, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy